Hepatocellular carcinoma: Difference between revisions
No edit summary |
|||
Line 40: | Line 40: | ||
==Treatment== | ==Treatment== | ||
'''Medical therapy:''' [[Hepatocellular carcinoma medical therapy#Percutaneous ethanol injection|Percutaneous ethanol injection]] | [[Hepatocellular carcinoma medical therapy#Transcatheter arterial chemoembolization (TACE)|Transcatheter arterial chemoembolization (TACE)]] | [[Hepatocellular carcinoma medical therapy#Sealed source radiotherapy|Sealed source radiotherapy]] | [[Hepatocellular carcinoma medical therapy#Radiofrequency ablation (RFA)|Radiofrequency ablation (RFA)]] | [[Hepatocellular carcinoma medical therapy#Intra-arterial iodine-131–lipiodol administration|Intra-arterial iodine-131–lipiodol administration]] | [[Hepatocellular carcinoma medical therapy#High intensity focused ultrasound (HIFU)|High intensity focused ultrasound (HIFU)]] | [[Hepatocellular carcinoma medical therapy#Hormonal therapy|Hormonal therapy]] | [[Hepatocellular carcinoma medical therapy#Chemotherapy|Chemotherapy]] | '''Medical therapy:''' [[Hepatocellular carcinoma medical therapy#Percutaneous ethanol injection|Percutaneous ethanol injection]] | [[Hepatocellular carcinoma medical therapy#Transcatheter arterial chemoembolization (TACE)|Transcatheter arterial chemoembolization (TACE)]] | [[Hepatocellular carcinoma medical therapy#Sealed source radiotherapy|Sealed source radiotherapy]] | [[Hepatocellular carcinoma medical therapy#Radiofrequency ablation (RFA)|Radiofrequency ablation (RFA)]] | [[Hepatocellular carcinoma medical therapy#Intra-arterial iodine-131–lipiodol administration|Intra-arterial iodine-131–lipiodol administration]] | [[Hepatocellular carcinoma medical therapy#High intensity focused ultrasound (HIFU)|High intensity focused ultrasound (HIFU)]] | [[Hepatocellular carcinoma medical therapy#Hormonal therapy|Hormonal therapy]] | [[Hepatocellular carcinoma medical therapy#Chemotherapy|Chemotherapy]] | ||
====Contraindicated medications==== | |||
{{MedCondContrAbs | |||
|MedCond = Hepatocellular carcinoma|Norethindrone acetate and ethinyl estradiol}} | |||
'''Surgery:''' [[Hepatocellular carcinoma surgery#Liver transplant|Liver transplant]] | [[Hepatocellular carcinoma surgery#Surgical resection|Surgical resection]] | [[Hepatocellular carcinoma surgery#Cryosurgery|Cryosurgery]] | '''Surgery:''' [[Hepatocellular carcinoma surgery#Liver transplant|Liver transplant]] | [[Hepatocellular carcinoma surgery#Surgical resection|Surgical resection]] | [[Hepatocellular carcinoma surgery#Cryosurgery|Cryosurgery]] | ||
'''Prevention:''' [[Hepatocellular carcinoma primary prevention|Primary prevention]] | [[Hepatocellular carcinoma secondary prevention|Secondary prevention]] | '''Prevention:''' [[Hepatocellular carcinoma primary prevention|Primary prevention]] | [[Hepatocellular carcinoma secondary prevention|Secondary prevention]] | ||
==Resources== | ==Resources== |
Revision as of 20:47, 6 October 2014
Hepatocellular carcinoma | |
Hepatocellular Carcinoma, Hepatitis C positive. Tumor growth in portal vein | |
ICD-10 | C22.0 |
ICD-9 | 155 |
ICD-O: | 8170/3 |
MedlinePlus | 000280 |
Hepatocellular carcinoma Microchapters |
Differentiating Hepatocellular carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hepatocellular carcinoma On the Web |
American Roentgen Ray Society Images of Hepatocellular carcinoma |
Risk calculators and risk factors for Hepatocellular carcinoma |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Hepatoma; malignant hepatoma; liver cancer; malignant liver tumor; primary liver cell carcinoma
Overview
Historical perspective
Pathophysiology
Causes
Differentiating Hepatocellular carcinoma from other Diseases
Epidemiology & Demographics
Risk factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Lab Studies | Electrocardiogram | Chest X Ray | MRI | CT | Ultrasound | Other imaging findings | Other diagnostic studies
Treatment
Medical therapy: Percutaneous ethanol injection | Transcatheter arterial chemoembolization (TACE) | Sealed source radiotherapy | Radiofrequency ablation (RFA) | Intra-arterial iodine-131–lipiodol administration | High intensity focused ultrasound (HIFU) | Hormonal therapy | Chemotherapy
Contraindicated medications
Hepatocellular carcinoma is considered an absolute contraindication to the use of the following medications:
Surgery: Liver transplant | Surgical resection | Cryosurgery
Prevention: Primary prevention | Secondary prevention
Resources
Template:Gastroenterology
Template:Tumors
Template:Tumor morphology
de:Leberzellkarzinom fi:Maksasyöpä hr:Rak jetre hu:Májtumor la:Carcinoma hepatocellulare ko:간암 nl:Leverkanker no:Leverkreft sv:Levercancer